Share

Why choose oncology?

In this EJC News Focus, several key opinion leaders in oncology, EORTC Director General Françoise Meunier, Rob Coleman of the University of Sheffield, Fatima Cardoso of the Champalimaud Cancer Center, ESMO President Martine Piccart, and Kathy Pritchard of the University of Toronto, discuss what the specialty has to offer, the impending shortage of oncologists, and also – how those setting out can best position themselves in the early years of their career.

Video compliments of the European Journal of Cancer

Back to news list

Related News

  • EORTC: Advancing research and treatment for rare cancers

  • EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration

  • Appointment of Malte Peters as EORTC Strategic Alliance Officer

  • Unique series of workshops in partnership with the European Medicines Agency (EMA)

  • EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)

  • Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023

  • EORTC Quality of Life measures integrated in CDISC

  • EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma

  • Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia

  • New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023